(Health-NewsWire.Net, January 18, 2016 ) Massive unexplored injectable drug delivery market in emerging economies and development of biosimilars and biologics are creating ample opportunities for the global injectable drug delivery market to grow at a considerable rate in the coming years. The advanced research and development facilities and new product developments by the companies are propelling the demand for cost effective and efficient injectable drug delivery devices and formulations.
Explore more or request TOC on Global Injectable Drug Delivery Market at: https://www.psmarketresearch.com/market-analysis/injectable-drug-delivery-market
Significant shift from conventional injectable drug delivery devices to self-injection drug delivery devices is a trend in global injectable drug delivery market. Increasing prevalence of diabetes has fuelled the demand of self-injection drug delivery devices; hence, reducing frequent hospital visits and costs related to it. According to the International Diabetes Federation (IDF), in 2013, there were 381.8 million people living with diabetes across the globe and the number was expected to grow to 591.9 million by 2035.
Geographically, North America will be leading the global injectable drug delivery market in the coming years due to high prevalence of cancer and diabetes cases, and high patient compliance for injectable drug delivery devices. Asia-Pacific is the fastest growing region in the global injectable drug delivery market. The major reasons for the fastest growth in the region are increasing disposable income, large pool of population base and improving healthcare infrastructure. Moreover, the injectable drug delivery market is growing rapidly due to large unexplored injectable drug delivery market and increasing awareness of injectable drug delivery systems in emerging economies, such as India and China, of Asia-Pacific region.
Browse related market research at: https://www.psmarketresearch.com/industry-report/healthcare
Some of the major players operating in the global injectable drug delivery market are Becton, Dickinson and Company, Baxter International, Inc., Novo Nordisk A/S, Terumo Medical Corp., Sanofi, Schott AG, Ypsomed Holding AG, Antares Pharma, Inc., Owen Mumford Ltd., Eli Lilly And Company, and Zogenix, Inc. among others.
About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Contact:
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
US/ Canada Toll-Free: 1-888-778-7886
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
P&S Market Research
Abhishek
1-888-778-7886
enquiry@psmarketresearch.com
Source: EmailWire.Com
|